Parallax Volatility Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-910
Closed -$235K 1796
2025
Q2
$235K Sell
910
-2,650
-74% -$632K ﹤0.01% 1303
2025
Q1
$797K Buy
+3,560
New +$831K ﹤0.01% 1108
2024
Q1
Sell
-563
Closed -$96.8K 2264
2023
Q4
$96.8K Sell
563
-2,546
-82% -$391K ﹤0.01% 1874
2023
Q3
$460K Buy
3,109
+1,775
+133% +$321K ﹤0.01% 1631
2023
Q2
$291K Buy
+1,334
New +$297K ﹤0.01% 1813
2022
Q4
Sell
-254
Closed -$55K 3196
2022
Q3
$55K Buy
+254
New +$57.8K ﹤0.01% 2600
2022
Q2
Sell
-680
Closed -$145K 3201
2022
Q1
$165K Sell
680
-395
-37% -$95.5K ﹤0.01% 2244
2021
Q4
$280K Sell
1,075
-379
-26% -$98.3K ﹤0.01% 2362
2021
Q3
$383K Buy
1,454
+215
+17% +$58.8K ﹤0.01% 2319
2021
Q2
$305K Buy
+1,239
New +$260K ﹤0.01% 2342
2021
Q1
Sell
-955
Closed -$203K 3591
2020
Q4
$203K Sell
955
-137
-13% -$27.3K ﹤0.01% 2777
2020
Q3
$187K Sell
1,092
-930
-46% -$172K ﹤0.01% 2569
2020
Q2
$388K Buy
2,022
+477
+31% +$78K ﹤0.01% 2057
2020
Q1
$228K Buy
+1,545
New +$246K ﹤0.01% 1961
2019
Q1
Sell
-9
Closed -$1K 3803
2018
Q4
$1K Buy
9
+3
+50% +$321 ﹤0.01% 2797
2018
Q3
$1K Buy
+6
New +$657 ﹤0.01% 2484
2018
Q1
Sell
-3,361
Closed -$285K 3873
2017
Q4
$285K Buy
+3,361
New +$278K ﹤0.01% 1980
2014
Q4
Sell
-4,693
Closed -$245K 5684
2014
Q3
$231K Sell
4,693
-15,237
-76% -$776K ﹤0.01% 2368
2014
Q2
$1.01M Buy
+19,930
New +$988K ﹤0.01% 1043

Other funds holding RMD

Parallax Volatility Advisers's RMD Position: Q3 2025 in Review

Parallax Volatility Advisers sold out of ResMed (RMD) in Q3 2025, closing a stake of 910 shares — an estimated $235K sold.

Parallax Volatility Advisers first reported a position in RMD in Q2 2014 and held it in 19 quarters. The position peaked at $1.01M in Q2 2014. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Parallax Volatility Advisers reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 910 ResMed shares in Q3 2025, an estimated $235K.
  • Parallax Volatility Advisers first reported a position in ResMed in Q2 2014 and held it in 19 quarters.
  • Parallax Volatility Advisers's ResMed position peaked at $1.01M in Q2 2014.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Parallax Volatility Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.